<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article article-type="research-article" dtd-version="3.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">GYA</journal-id>
<journal-title-group>
<journal-title>Grasas y Aceites</journal-title>
</journal-title-group>
<issn pub-type="epub">0017-3495</issn>
<publisher>
<publisher-name>Consejo Superior de Investigaciones Cientificas</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">GYA201946_e325-1052182</article-id>
<article-id pub-id-type="doi">10.3989/gya.1052182</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Synthesis, characterization and evaluation of 1-monoacylglycerols of unsaturated fatty acids as potential bioactive lipids</article-title>
<trans-title-group xml:lang="es">
<trans-title>S&#x00ED;ntesis, caracterizaci&#x00F3;n y evaluaci&#x00F3;n de 1-monoacilgliceroles de &#x00E1;cidos grasos insaturados como potenciales l&#x00ED;pidos bioactivos</trans-title>
</trans-title-group>
<alt-title alt-title-type="running-head">Synthesis, characterization and evaluation of 1-monoacylglycerols of unsaturated fatty acids as potential bioactive lipids</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Johny</surname>
<given-names>J.</given-names>
</name>
<xref ref-type="aff" rid="aff0001">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jatla</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="aff0002">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eruva</surname>
<given-names>V.K.</given-names>
</name>
<xref ref-type="aff" rid="aff0002">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Misra</surname>
<given-names>S.</given-names>
</name>
<xref ref-type="aff" rid="aff0002">b</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kaki</surname>
<given-names>S.S.</given-names>
</name>
<xref ref-type="aff" rid="aff0001">a</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="aff0001"><label>a</label>Centre for Lipid Science &#x0026; Technology</aff>
<aff id="aff0002"><label>b</label>Applied Biology, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, India</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Corresponding author: <email xlink:href="sskaki@iict.res.in">sskaki@iict.res.in</email></corresp>
<fn><p><bold>ORCID ID:</bold> Johny J <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-3109-5519">https://orcid.org/0000-0003-3109-5519</ext-link>, Jatla A <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-4240-5148">https://orcid.org/0000-0003-4240-5148</ext-link>, Eruva VK <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-1015-3660">https://orcid.org/0000-0003-1015-3660</ext-link>, Misra S <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-3080-7476">https://orcid.org/0000-0002-3080-7476</ext-link>, Kaki SS <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0003-2726-1166">http://orcid.org/0000-0003-2726-1166</ext-link></p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>31</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>70</volume>
<issue>4</issue>
<elocation-id content-type="doi">10.3989/gya.1052182</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>12</month>
<year>2018</year>
</date>
<date date-type="published online">
<day>17</day>
<month>07</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2019 CSIC</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) License.</license-p>
</license>
</permissions>
<abstract>
<title>SUMMARY</title>
<p>The synthesis of 1-monoacylglycerols of selected unsaturated fatty acids and their antimicrobial and cytotoxicity activity is reported in the present study. The monoacylglycerols of fatty acids like undecenoic, oleic, linoleic and erucic acids were prepared by chemical esterification with solketal followed by deprotection. Fatty acids like alpha linolenic, gamma linolenic and ricinoleic acids were initially isolated from natural sources and further enriched in their respective methyl ester forms. The monoacylglycerols of ricinoleic and linolenic acid methyl esters were prepared by enzymatic transesterification with solketal using lipase from <italic>Candida antarctica</italic> followed by deprotection. The synthesized 1-monoacylglycerols were purified and characterized by spectral studies. The antimicrobial activity revealed that the monoacylglycerol of gamma linolenic acid was the most effective antibacterial followed by the monoacylglycerols of undecenoic and alpha linolenic acids. In the cytotoxicity assay against five cell lines, all the monoacylglycerols exhibited moderate activity but the activity was best against MCF7 Human Breast Adenocarcinoma cell lines.</p>
</abstract>
<trans-abstract xml:lang="es">
<title>RESUMEN</title>
<p><bold><italic>S&#x00ED;ntesis, caracterizaci&#x00F3;n y evaluaci&#x00F3;n de 1-monoacilgliceroles de &#x00E1;cidos grasos insaturados como potenciales l&#x00ED;pidos bioactivos.</italic></bold> La s&#x00ED;ntesis de 1-monoacilgliceroles de &#x00E1;cidos grasos insaturados seleccionados y su actividad antimicrobiana y citotoxicidad se describen en el presente estudio. Los monoacilgliceroles de &#x00E1;cidos grasos como los &#x00E1;cidos undecenoico, oleico, linoleico y er&#x00FA;cico se prepararon mediante esterificaci&#x00F3;n qu&#x00ED;mica con solketal seguido de desprotecci&#x00F3;n. Los &#x00E1;cidos grasos como el alfa-linol&#x00E9;nico, gamma-linol&#x00E9;nico y ricinoleico se aislaron inicialmente de fuentes naturales y se enriquecieron a&#x00FA;n m&#x00E1;s en sus respectivos &#x00E9;steres met&#x00ED;licos. Los monoacilgliceroles de los &#x00E9;steres met&#x00ED;licos de los &#x00E1;cidos ricinoleico y linol&#x00E9;nico se prepararon mediante transesterificaci&#x00F3;n enzim&#x00E1;tica con solketal utilizando lipasa de <italic>Candida ant&#x00E1;rctica</italic> seguido de desprotecci&#x00F3;n. Los 1-monoacilgliceroles sintetizados se purificaron y caracterizaron mediante estudios espectrales. La actividad antimicrobiana mostr&#x00F3; que el monoacilglicerol del &#x00E1;cido gamma-linol&#x00E9;nico fue el antibacteriano m&#x00E1;s eficaz seguido del monoacilglicerol de los &#x00E1;cidos undecenoico y alfa-linol&#x00E9;nico. En el ensayo de citotoxicidad contra cinco l&#x00ED;neas celulares, todos los monoacilgliceroles mostraron una actividad moderada, pero la actividad fue mejor contra las l&#x00ED;neas celulares de adenocarcinoma de mama humano MCF7.</p>
</trans-abstract>
<kwd-group xml:lang="en">
<title>KEYWORDS</title>
<kwd>1-monoacylglycerols</kwd>
<kwd>Antimicrobial activity</kwd>
<kwd>Cytotoxicity</kwd>
<kwd>Fatty acids</kwd>
<kwd>Lipids</kwd>
<kwd>Synthesis</kwd>
</kwd-group>
<kwd-group xml:lang="es">
<title>PALABRAS CLAVE</title>
<kwd>1-monoacilgliceroles</kwd>
<kwd>&#x00C1;cidos grasos</kwd>
<kwd>Actividad antimicrobiana</kwd>
<kwd>Citotoxicidad</kwd>
<kwd>L&#x00ED;pidos</kwd>
<kwd>S&#x00ED;ntesis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<title>1. INTRODUCTION</title>
<p>Structured lipids have gained importance in specialty foods which include modified lipids ranging from glycerides to phospholipids and are produced for specific food, nutritional and biomedical applications. (Osborn and Akoh <xref ref-type="bibr" rid="cit0021">2002</xref>). Among these structured lipids, monoacylglycerols (MAGs) are well known for their use as emulsifying agents and as carriers of nutrients in food applications for improved bioavailability (Lu <italic>et al</italic>., <xref ref-type="bibr" rid="cit0018">2017</xref>). In addition to this, MAGs are also known for their antimicrobial activity and are reported to exert stronger antimicrobial activity than their corresponding free fatty acids (Kabara <italic>et al</italic>., <xref ref-type="bibr" rid="cit0012">2005</xref>). In light of the emerging antimicrobial resistance towards conventional antimicrobials, interest in the development of new agents which are non-toxic or less toxic in nature led to interest in alternative agents. In this context, lipids and their derivatives are receiving renewed interest as they are obtained from natural sources and are generally regarded as safe and non-toxic (Littich <italic>et al</italic>., <xref ref-type="bibr" rid="cit0017">2017</xref>). Among the bioactive structured lipids, MAGs are known to play an important role as drug carriers in formulations in the cosmetic and pharmaceutical industries (Pawongrat <italic>et al</italic>., <xref ref-type="bibr" rid="cit0023">2008</xref>). Among the various MAGs studied, 1-monolaurin is the only MAG which is widely studied and is reported to exert antimicrobial effect as studied by Jon J.Kabara&#x2019;s group and other researchers (Kabara <italic>et al</italic>., <xref ref-type="bibr" rid="cit0013">1972</xref>; Altieri <italic>et al</italic>., <xref ref-type="bibr" rid="cit0003">2009</xref>). The industrial production of MAGs is carried out by the glycerolysis of natural fats and oils. However, the preparation of structured MAGs can be achieved with different methods by chemical and enzymatic processes which are reported in the literature. These include the glycerolysis of triacyglycerols with glycerol in the presence of inorganic catalysts at high temperatures (Sontag <xref ref-type="bibr" rid="cit0026">1982</xref>), the reaction of fatty acids and glycidol catalyzed by chromium-fatty acid complexes (Janis <italic>et al</italic>., <xref ref-type="bibr" rid="cit0025">2000</xref>) and by enzymatic methods (Bornscheuer <xref ref-type="bibr" rid="cit0005">1995</xref>).</p>
<p>Research in this area is gaining importance because of the potential benefits of MAGs such as their biocompatibility and biodegradable nature. There are reports on the higher activity of unsaturated fatty acids compared to saturated fatty acids on some microbial strains (Zheng <italic>et al</italic>., <xref ref-type="bibr" rid="cit0030">2005</xref>). It was recently reported that long-chain poly unsaturated fatty acids have potential as topical antimicrobials against Gram-positive bacteria along with anti-inflammatory properties (Desbois <italic>et al</italic>., <xref ref-type="bibr" rid="cit0008">2013</xref>). Though there are reports on the antimicrobial studies of MAGs of some unsaturated fatty acids, there are no reports on the cytotoxic evaluation of MAGs of unsaturated fatty acids. The objective of the present study is to prepare and characterize the MAGs of selected unsaturated fatty acids and examine their antimicrobial and cytotoxic activities which could expand their application in food and biomedical applications. The unsaturated fatty acids namely undecenoic, oleic, ricinoleic, linoleic, alpha linolenic, gamma linolenic and erucic acids were selected for the study. Undecenoic acid is well known for its antifungal activity and also for its application in pharmaceutical and cosmetic products (Pierard <italic>et al</italic>., <xref ref-type="bibr" rid="cit0024">1997</xref>). Oleic acid is known for its emollient properties and is reported to help as a carrier for medicinal and cosmetic ingredients for delivery through the skin (Aarti <italic>et al</italic>., <xref ref-type="bibr" rid="cit0001">1995</xref>).</p>
<p>Linoleic acid is a nutritionally important fatty acid whose intake is reported to have inverse effects on heart diseases and cholesterol levels (Maryam <italic>et al</italic>., <xref ref-type="bibr" rid="cit0019">2014</xref>). The polyunsaturated fatty acids (PUFAs) ALA and GLA are nutraceutically and physiologically important fatty acids which are known for their numerous nutritional and health benefits. (Flider, <xref ref-type="bibr" rid="cit0010">2005</xref>; Nguemeni <italic>et al</italic>., <xref ref-type="bibr" rid="cit0020">2013</xref>). Erucic acid is mainly obtained from mustard oil, high erucic acid rapeseed oil and is widely known for its industrial applications. Ricinoleic acid, a hydroxyl group containing fatty acid obtained from castor oil is known for many medicinal applications (Pabi&#x015B; <italic>et al</italic>., <xref ref-type="bibr" rid="cit0022">2016</xref>). Owing to the beneficial properties of unsaturated fatty acids, the study of 1-MAGs of these fatty acids could be of interest as they can have potential bioactive applications. Hence the present study was aimed to investigate and evaluate the synthesis and antimicrobial and cytotoxicity activity of 1-MAGs from these selected unsaturated atty acids.</p>
</sec>
<sec id="sec2" sec-type="materials|methods">
<title>2. MATERIALS AND METHODS</title>
<sec id="sec2.1">
<title>2.1. Materials and instruments</title>
<p>Oleic and linoleic acids were purchased from TCI chemicals, India. Solketal, erucic acid and borage oil were purchased from Sigma Aldrich. Eripupae were obtained from the Central Silk Board, Bengaluru, India. Castor oil was purchased from a local market. N,N<sup>&#x2019;</sup>-Dicyclohexyl carbodiimide (DCC), 4-Dimethylaminopyridine (DMAP) were obtained from SRL. Penicillin and Streptomycin were used as standard drugs. All solvents were purchased from Merck and used without further purification. The proton NMR spectra were recorded on a Varian 400 MHz instrument and TMS was used as internal standard. Mass spectra were recorded using electron spray ionization on a Waters e2695 Separator module (Waters, Milford, MA, USA) mass spectrometer. IR spectra were recorded in dichloromethane on a Perkin-Elmer Fourier transform (FT)-IR Spectrum BX instrument (Model: Spectrum BX; Connecticut, USA). All the synthesized products were purified by silica gel (60&#x2013; 120 mesh) column chromatography (Acme Synthetic Chemicals, Mumbai, India) and identified by thin-layer chromatography (TLC). TLC was performed on pre-coated silica gel 60 F<sub>254</sub> from Merck (Darmstadt, Germany).</p>
</sec>
<sec id="sec2.2">
<title>2.2. Isolation and enrichment of fatty acids from natural sources</title>
<sec id="s2b1">
<title>2.2.1. Preparation of PUFA fractions from oils</title>
<p>For gamma linolenic acid and alpha linolenic acid, borage oil and eri silkworm oil were chosen as substrates. Both silkworm oil and borage oils were converted to fatty acid methyl esters according to the reported method. Briefly, the oils were refluxed in a 2% sulfuric acid-methanol reagent for 3 hours. After complete conversion as monitored by TLC, the solvent was evaporated and the contents were transferred to a separating funnel and ethyl acetate was added and washed with distilled water until neutral. The organic phase was dried over anhydrous sodium sulphate and concentrated to obtain the fatty acid methyl esters (Christie <xref ref-type="bibr" rid="cit0006">1982</xref>). The resulting methyl esters were subjected to urea crystallization for enrichment of PUFA following previously reported protocols (Kaki <italic>et al</italic>., <xref ref-type="bibr" rid="cit0014">2014</xref>).</p>
</sec>
<sec id="s2b2">
<title>2.2.2. Isolation of pure methyl ricinoleate from castor oil</title>
<p>Castor oil (15 g) was converted to methyl esters using 300 mL of 2%-sulphuric acid methanol reagent for 3 hours at 75 &#x00B0;C with magnetic stirring. After complete conversion as monitored by TLC, the solvent was evaporated and the contents were transferred to a separating funnel and ethyl acetate (150 mL x2) was added and washed with distilled water until neutral. The organic phase was dried over anhydrous sodium sulphate and concentrated to obtain fatty acid methyl esters. The methyl esters (10 g) were separated into pure methyl ricinoleate (9.04 g; 90% yield) and non-hydroxy fatty acid methyl esters following a reported protocol (Berdeaux <italic>et al</italic>., <xref ref-type="bibr" rid="cit0004">1997</xref>). Castor oil FAME (10 g) was shaken with 300 mL hexane and 150 mL 90% aq. methanol. After the layers were separated, the methanolic phase was collected and the hexane phase was washed again with fresh 90% aq. methanol (100 mL). The two fractions were monitored by TLC for purity of methyl ricinoleate. Finally, methanol was evaporated from the fraction which showed only the presence of methyl ricinoleate and ethyl acetate was added followed by brine and water wash. Later the methyl ricinoleate fraction was dried over anhydrous sodium sulphate and the solvent was evaporated to yield pure methyl ricinoleate with 90% yield (9.04 g). The castor oil methyl esters and enriched methyl ricinoleate samples were analyzed by gas chromatography for determining the fatty acid composition.</p>
</sec>
<sec id="s2b3">
<title>2.2.3. Gas chromatography</title>
<p>Two temperature programs were employed for the gas chromatographic (GC) analysis. For normal fatty acid methyl esters, GC was performed on an Agilent 6890 gas chromatograph equipped with a flame ionization detector. The column used was a DB-225 with a length of 30 m, 0.25 mm i.d and 25 &#x03BC;m film thickness. The carrier gas was nitrogen at a flow rate of 1 mL/min. The oven programming was as follows: 160 &#x00B0;C for 2 minutes, raised to 230 &#x00B0;C at a rate of 5 &#x00B0;C/min and held at 230 &#x00B0;C for 20 minutes. The injector and detector temperatures were maintained at 220 and 250 &#x00B0;C, respectively. For castor oil fatty acid methyl esters, GC was performed using an Agilent 6890 gas chromatograph coupled with a FID. A HP-1 capillary column (30 m x 0.25 mm x 0.25 &#x03BC;m, (Agilent) was used with a column temperature program of 160&#x00B0;C for 2 min, raised at 10 &#x00B0;C/min to 300 &#x00B0;C and held for 20 min at 300 &#x00B0;C. The injector temperature was 280 &#x00B0;C with a split ratio of 50:1. The carrier gas was nitrogen at a flow rate of 1 mL/min. The detector temperature was 300 &#x00B0;C with air and hydrogen flow rates of 300 mL/min and 30 mL/min, respectively. The fatty acids were identified by comparing the retention times with those of standard fatty acid methyl esters.</p>
</sec>
</sec>
<sec id="sec2.3">
<title>2.3. Synthesis of 1-monoacylglycerols of unsaturated fatty acids</title>
<sec id="s2c1">
<title>2.3.1. Synthesis of 1-monoacylglycerols</title>
<p>The synthesis of 1-monoacylglycerols was carried out in two steps following a reported protocol with slight modifications (Yang <italic>et al</italic>., <xref ref-type="bibr" rid="cit0028">2012</xref>).</p>
</sec>
<sec id="s2c2">
<title>2.3.2. Esterification of solketal with fatty acids</title>
<p>The esterification of oleic acid with solketal is described as an example. In a 100 mL round-bottomed flask, solketal (0.79 g, 0.006 moles) was dissolved in dichloromethane (15 mL) and DMAP (0.2 eq, 0.12 g) was added at 0 &#x00BA;C. A mixture of DCC (1 eq, 1.03 g) and oleic acid (1 eq, 1.41 g, 0.005 moles) was added and dissolved in 20 mL dichloromethane. The ice bath was removed and the reaction was stirred at room temperature for 24h. After 24 h, the reaction mixture was filtered to remove the precipitate. The filtrate containing the product was washed with saturated aqueous sodium bicarbonate (50 mL) and water (3 x 75 mL) and the organic layer was dried over anhydrous sodium sulphate and concentrated by rotary evaporation at 45 &#x00BA;C to obtain the crude product. The crude product was purified by silica gel (60&#x2013;120 mesh) column chromatography using hexane and ethyl acetate gradient to obtain pure acetonide at a 70% yield (1.39 g). The product was concentrated and characterized using 1H-NMR, IR and mass spectral data. A similar protocol was followed for the esterification of undecenoic, linoleic and erucic acids to obtain the corresponding acetonides.</p>
</sec>
<sec id="s2c3">
<title>2.3.3. Transesterification of ricinoleic acid methyl ester with solketal</title>
<p>Ricinoleic acid methyl ester (1.5 g; 00 4.8mmol) and solketal (0.69 g; 5.28 mmol) were mixed together. The lipase from <italic>C. antarctica</italic> (10% to wt of substrates) was added and the reaction mixture was magnetically stirred at 60 &#x00BA;C under vacuum. After maximum conversion as observed by TLC, ethyl acetate was added to the reaction medium and the lipase was separated by filtration. The filtered lipase was washed with ethyl acetate and the combined ethyl acetate filtrate was evaporated to obtain the crude reaction product. The crude product was purified by column chromatography on silica gel (60&#x2013;120 mesh) using a gradient of hexane and ethyl acetate to obtain pure acetonide at a 73% yield (1.36 g). Similarly, the ALA methyl ester and GLA methyl esters were transesterified with solketal to obtain the respective acetonides at 45 and 61% yields, respectively.</p>
</sec>
<sec id="s2c4">
<title>2.3.4. Spectral data of acetonides</title>
<p>(2, 2-dimethyl-1, 3-dioxolan-4-yl) methyl undec-10-enoate (1a); Yield: 60%; 1H NMR (400 MHz, CDCl3) &#x03B4;: 1.31 (d, J = 15.7 Hz,-CH3-, 6H), 1.50 &#x2013; 1.34 (m,-CH2-, 6H), 1.69 &#x2013; 1.55 (m, -CH2-, 2H), 2.08 &#x2013; 1.99 (m, CH2-, 2H), 2.34 (t, J = 15.2 Hz,-CH2-, 2H), 3.74 (dd, J = 8.4Hz, 6.2 Hz,-CH-, 1H), 4.13 &#x2013; 4.05 (m,-CH2- , 2H), 4.17 (dd, J = 11.5Hz, 4.7 Hz, -CH-, 1H), 4.31 (m, -CH-, 1H), 5.06 &#x2013; 4.89 (m,-CH2-, 2H), 5.81 (m, -CH-, 1H); IR (cm-1): 1741cm<sup>-1</sup>, 2928, 2855cm<sup>-1</sup>, 3076cm<sup>-1</sup> MS: m/z 321.33 [M<sup>+</sup>23] .</p>
<p>(2, 2-dimethyl-1, 3-dioxolan-4-yl) methyl oleate (1b); Yield: 70%; 1H NMR (400 MHz, CDCl3) &#x03B4;: 0.89 (t, J = 6.72Hz, CH3, 3H), 1.34 - 1.26 (m, (CH2)10, 20H), 1.63 - 1.58 (m, CH2, 2H), 2.03 - 1.98 (m, (CH2)2, 4H), 2.36 - 2.32 (t, J = 7.4 Hz, CH2, 2H), 3.75 - 3.71 (m, CH, 1H), 4.18 - 4.05 (m, CH, CH2, 3H), 4.34 &#x2013; 4.28 (m, CH, 1H), 5.38 - 5.30 (m, (=CH)2, 2H); MS: m/z 419 [M<sup>+</sup>23]</p>
<p>(9Z,12Z)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl octadeca-9,12-dienoate (1c); Yield: 90 %; 1H NMR (400 MHz, CDCl3) &#x03B4;: 0.89 (t, J = 8.2 Hz, CH3, 3H), 1.41 &#x2013; 1.18 (m,(CH2)9, 18H), 1.48 &#x2013; 1.40 (m, CH2, 2H), 1.70 &#x2013; 1.59 (m, CH2, 2H), 2.05 (q, J = 6.8 Hz, CH2, 4H), 2.35 (t, J = 6.95 Hz, 6.4 Hz, CH2, 2H), 2.77 (t, J = 6.5 Hz, 2H), 3.74 (m, CH, 1H), 4.38 &#x2013; 4.00 (m, (CH2)2, 4H), 5.49 &#x2013; 5.24 (m ,( CH)4, 4H); IR: 1735cm<sup>-1</sup>, 2875.50 cm<sup>-1</sup>, 2966.43 cm<sup>-1</sup>; MS: m/z = 417.47 [M<sup>+</sup>23]</p>
<p>(6Z,9Z,12Z)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl octadeca-6,9,12-trienoate (1d); Yield: 61%; 1H NMR (400 MHz, CDCl3) &#x03B4;: 0.89 (t, J = 6.91 Hz, CH3, 3H), 1.47 &#x2013; 1.31 (m, (CH2)6, 12H), 1.74 &#x2013; 1.59 (m, CH2, 2H), 2.11-2.03 (m, (CH2)2, 4H), 2.36 (t, J = 7.51 Hz, CH2, 2H), 2.96 &#x2013; 2.63 (m, (CH2)2, 4H), 3.75-3.71 (m, CH, 1H), 4.44 &#x2013; 3.98 (m, (CH2)2, 4H), 5.49 &#x2013; 5.25 (m, (CH)6, 6H). IR: 1737 cm<sup>-1</sup>, 2859 cm<sup>-1</sup>, 2929 cm<sup>-1</sup>, 3013 cm-1; Mass: m/z 415.32 [M<sup>+</sup>23]</p>
<p>(9Z,12Z,15Z)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl octadeca-9,12,15-trienoate (1e); Yield: 45%; 1H NMR (400 MHz, CDCl3) &#x03B4; 0.97 (t, J = 7.51 Hz, CH3, 3H), 1.34 &#x2013; 1.24 (m, (CH2)6, 12H), 1.65 &#x2013; 1.61 (m, CH2, 2H), 2.09 &#x2013; 2.03 (m, CH2, 2H), 2.34 (t, J =7.51 Hz, CH2, 2H), 2.86 &#x2013; 2.73 (m, (CH2)2, 4H), 3.76 &#x2013; 3.72 (m, CH2, 2H), 4.20 &#x2013; 4.05 (m, (CH2)2, 4H), 4.37 &#x2013; 4.29 (m, CH, 1H), 5.44 &#x2013; 5.27 (m, (=CH)6, 6H); IR: 1265.58 cm-1, 1736.82 cm<sup>-1</sup>, 2856.53 cm<sup>-1</sup>, 2930 cm<sup>-1</sup>, 3054.80 cm<sup>-1</sup>; Mass: m/z 415.28 [M<sup>+</sup>23]</p>
<p>(Z)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl docos-13-enoate (1f); Yield: 82%; 1H NMR (400 MHz) &#x03B4;: 0.89 (t, J = 6.78 Hz, CH3, 3H) , 1.36 &#x2013; 1.22 (m, (CH2)16, 32H), 1.66 &#x2013; 1.60 (m, CH2, 2H), 1.98 - 2.06 (m, CH2, 4H), 2.34 (t, J = 7.58 Hz, CH2, 3H), 3.69 - 3.78 (m, CH, 1H), 4.37 &#x2013; 3.99 (m, (CH2)2, 4H), 5.39 &#x2013; 5.31 (m, (=CH)2, 2H); IR: 1733cm<sup>-1</sup>, 2857 cm<sup>-1</sup>, 2927 cm<sup>-1</sup>, 3018 cm<sup>-1</sup>; MS: m/z 475 [M<sup>+</sup>23]</p>
<p>(Z)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl 12-hydroxyoctadec-9-enoate (1g); Yield: 73%; 1H NMR (500 MHz, CDCl3) &#x03B4; 0.88 (t, J =6.90 Hz, CH3, 3H), 1.58 &#x2013; 1.53 (m, (CH2)10, 20H), 2.19 &#x2013; 2.15 (m, (CH2)5, 10H), 2.34 (t, J = 7.58 Hz, CH2, 2H), 3.75 &#x2013; 3.72 (m, CH, 1H), 4.20 &#x2013; 4.03 (m, CH2, 2H), 4.35 &#x2013; 4.27 (m, CH, 1H), 5.57 &#x2013; 5.37 (m, (CH)2, 2H); IR: 1216 cm<sup>-1</sup>, 1733cm<sup>-1</sup>, 2859cm<sup>-1</sup>, 2930cm<sup>-1</sup>, 3018cm<sup>-1</sup>, 3348cm<sup>-1</sup>; Mass: m/z 435.67 [M<sup>+</sup>23].</p>
</sec>
<sec id="s2c5">
<title>2.3.5. Hydrolysis of acetonide to 1-monoacylglycerols</title>
<p>The acetonide of oleic acid (1.25 g, 0.003 moles) dissolved in methanol (40 mL) in a round-bottomed flask was placed in an ice bath. To this cooled mixture, 2 M aqueous hydrochloric acid (2.4 mL, 1.6 eq) were added in one portion. After 15 min, the ice bath was removed and the reaction mixture was stirred for 5 hours at room temperature (20 &#x00BA;C) while monitoring by TLC at every hour. When the conversion was complete (5 h), the reaction mixture was diluted with 200 mL of diethyl ether, transferred to a separating funnel and washed with 200 mL of saturated aqueous sodium bicarbonate and extracted with diethyl ether (3 x 150 mL). The organic phases containing the product were dried over sodium sulphate and concentrated by rotary evaporation at 45 &#x00BA;C. The crude product was purified by silica gel column chromatography using a gradient of hexane and ethyl acetate to obtain the corresponding MAG at a 71% yield (0.8 g). The purified product was characterized using 1H-NMR, IR and mass spectral data. The other acetonides in the study were also hydrolyzed following the same methodology to obtain corresponding monoglycerides.</p>
</sec>
<sec id="s2c6">
<title>2.3.6. Spectral data of 1-MAGs</title>
<p>2,3-dihydroxypropyl undec-10-enoate (2a; UDA-MAG): Yield: 73%; H1-NMR (400 MHz, CDCl3) &#x03B4;: &#x03B4; 1.49 &#x2013; 1.18 (m, -CH2, 12H), 2.05 &#x2013; 2.00 (m, -CH2-, 2H), 2.45 &#x2013; 2.27 (m, -CH2-, 2H), 3.62 &#x2013; 3.58 (m, -OH, 1H), 3.71 &#x2013; 3.68 (m, -OH, 1H), 3.94 &#x2013; 3.90 (m, CH, 1H), 4.23 &#x2013; 4.12 (m, -CH2-, 2H), 5.05 &#x2013; 4.87 (m, -C-H-, 2H), 5.86 &#x2013; 5.74 (m, -C-H-, 1H); IR: 1729cm<sup>-1</sup> , 2928cm<sup>-1</sup>, 2856cm<sup>-1</sup>, 3015cm<sup>-1</sup>, 3407cm<sup>-1</sup>; MS: m/z 281.38 [M<sup>+</sup>23]</p>
<p>2, 3-dihydroxypropyl oleate (2b; Oleic-MAG): Yield: 71%; H1-NMR (400 MHz, CDCl3) &#x03B4;: 0.89 (t, J =6.84 Hz, CH3, 3H), 1.30 &#x2013; 1.26 (m, (CH2)20, 20H), 1.64 &#x2013; 1.59(m, CH2, 2H), 2.03 -1.98 (m, (CH2)2, 4H), 2.37 - 2.33 (t, 7.59 Hz, CH2, 2H), 3.71 - 3.57 (m, CH2, 2H), 3.95 -3.82 (m, CH, 1H), 4.22 &#x2013; 4.12 (m, CH2, 2H), 5.38 &#x2013; 5.30 (m, (=CH)2, 2H); IR (cm<sup>-1</sup>): 1730 cm<sup>-1</sup>, 2851 cm<sup>-1</sup>, 2926 cm<sup>-1</sup>, 3010 cm<sup>-1</sup>, 3404 cm<sup>-1</sup>; MS: m/z 379.46 [M<sup>+</sup>23]</p>
<p>(9Z, 12Z)-2, 3-dihydroxypropyl octadeca-9, 12-dienoate (2c; Linoleic-MAG): Yield: 72%; H1-NMR (400 MHz, CDCl3) &#x03B4;: 0.89 (t, 8.2 Hz, CH3, H), 1.24-1.43 (m, (CH2)7, 14H), 1.59-1.69 (m, CH2, 2H), 2.02-2.11(m, (CH2)2, 4H), 2.35 (t, J = 7.6 Hz, CH2, 2H), 2.77 (t, J = 6.5 Hz, CH, 1H), 3.58-3.72 (m, CH2, 2H), 3.82-3.96(m, CH, 1H) ,4.130 - 4.23 (m, CH2, 2H), 5.30 - 5.42 (m, (CH)4, 4H); IR: 1731.15 cm<sup>-1</sup>, 2856.27 cm<sup>-1</sup>, 2927.96 cm<sup>-1</sup>, 3010.51 cm<sup>-1</sup>, 3403.57 cm<sup>-1</sup>; Mass: m/z 377.41 [M<sup>+</sup>23]</p>
<p>(6Z, 9Z, 12Z)-2, 3-dihydroxypropyl octadeca-6, 9, 12-trienoate (2d; GLA-MAG): Yield: 76%; 1H NMR (400 MHz, CDCl3) &#x03B4;: 0.89 (t, J = 6.9 Hz, 3H), 1.47 &#x2013; 1.22(m, (CH2)4, 8H), 1.73 &#x2013; 1.60 (m, CH2, 2H), 2.11-2.10 (m, (CH2)2, 4H), 2.37 (t, 7.33 Hz, CH2, 2H), 2.89&#x2013;2.72 (m, (CH2)2, 4H), 3.97-3.56 (m,CH, CH2, 3H), 4.23-4.12 (m, CH2, 2H), 5.49 &#x2013; 5.23 (m, (CH)6, 6H); IR: 1737 cm<sup>-1</sup>, 2857 cm<sup>-1</sup>, 2927 cm<sup>-1</sup>, 3011 cm<sup>-1</sup>, 3382 cm<sup>-1</sup>; Mass: m/z 375.45 [M<sup>+</sup>23].</p>
<p>(9Z, 12Z, 15Z)-2,3-dihydroxypropyl octadeca-9,12,15-trienoate (2e; ALA-MAG): Yield: 72%; 1H NMR (400 MHz, CDCl3) &#x03B4; : 0.97 (t, 7.47Hz, CH3, 3H), 1.41 &#x2013; 1.27 (m, (CH2)4, 8H), 1.64 &#x2013; 1.60 (m, CH2, 2H), 2.11 &#x2013; 2.03 (m, (CH2)2, 4H), 2.35 (t, 7.47 Hz, CH2, 2H), 2.90 &#x2013; 2.72 (m, (CH2)2, 4H), 3.78 &#x2013; 3.50 (m, CH2, 2H), 4.00 &#x2013; 3.86 (m, CH, 1H), 4.22 &#x2013; 4.13 (m, CH2, 2H), 5.50 &#x2013; 5.18 (m, (CH)6, 6H); IR: 1265.18 cm-1, 1729 cm<sup>-1</sup>, 2928.70 cm<sup>-1</sup>, 3056.94 cm<sup>-1</sup>, 3383.57 cm<sup>-1</sup>; Mass: m/z 375.25 [M<sup>+</sup>23]</p>
<p>(Z)-2,3-dihydroxypropyl docos-13-enoate (2f; Erucic-MAG): Yield: 90%; 1H NMR (500 MHz) &#x03B4; 0.88 (t, J = 6.9 Hz, CH3, 3H), 1.38 &#x2013; 1.20 (m, (CH2)14, 28H), 1.60-1.66 (m, CH2, 2H), 1.99 - 2.01 (m, (CH2)2, 4H), 2.35 (t, J = 7.6 Hz, CH2, 2H), 3.72 &#x2013; 3.58 (m, CH2, 2H), 3.96 &#x2013; 3.90 (m, CH, 1H), 4.18 (m, CH2, 2H), A5.50 &#x2013; 5.09 (m, (=CH)2, 2H); IR: 1730 cm-1, 2856 cm<sup>-1</sup>, 2927 cm<sup>-1</sup>, 3021 cm<sup>-1</sup>, 3418 cm-1; Mass: m/z = 435 [M<sup>+</sup>23]</p>
<p>(Z)-2,3-dihydroxypropyl 12-hydroxyoctadec-9-enoate (2g; Ricinoleic-MAG): Yield: 80%; 1H NMR (400 MHz, CDCl3) &#x03B4; 0.89 (t, J = 6.8 Hz, CH3, 3H), 1.41 &#x2013; 1.22 (m, (CH2)8, 16H), 1.47 (t, J = 6.0 Hz, CH2, 2H), 1.69 &#x2013; 1.57 (m, CH2, 2H), 2.08 &#x2013; 2.03 (m, CH2, 2H), 2.21 (t, J = 6.3 Hz, CH2, 2H), 2.35 (t, 7.45 Hz, CH2, 2H), 3.66 &#x2013; 3.56 (m, CH2, 2H), 3.91 &#x2013; 3.98 ( m, CH, 1H), 3.96 &#x2013; 3.91 (m, CH, 1H), 4.23 &#x2013; 4.13 (m, 2H, 2H), 5.63 &#x2013; 5.32 (m, (=CH)2, 2H); IR: 1216 cm<sup>-1</sup>, 1728 cm<sup>-1</sup>, 2858 cm<sup>-1</sup>, 2929 cm<sup>-1</sup>, 3017 cm<sup>-1</sup>, 3389 cm<sup>-1</sup>; Mass: m/z 395.22 [M<sup>+</sup>23].</p>
</sec>
</sec>
<sec id="sec2.4">
<title>2.4. Antimicrobial and cytotoxic studies</title>
<sec id="s2d1">
<title>2.4.1. Antimicrobial activity</title>
<p>The in vitro antibacterial activity of the newly synthesized compounds was studied against the bacterial strains, <italic>Bacillus subtilis</italic> (MTCC 441), <italic>Staphylococcus aureus</italic> (MTCC 96), <italic>Staphylococcus epidermidis</italic> and <italic>Gram-negative</italic> organisms viz <italic>Escherichia coli</italic> (MTCC 443), <italic>Pseudomonas aeruginosa</italic> (MTCC 741), and <italic>Klebsiella pneumoniae</italic> (MTCC 618), according to the Agar Well Diffusion Method (Linday <xref ref-type="bibr" rid="cit0016">1962</xref>). The Nutrient Agar (NA) medium was suspended in distilled water (28 g in 1000 mL) and heated to boiling until it was dissolved completely. The medium and Petri dishes were autoclaved at a pressure of 15 psi for 20 min. The agar well bioassay was employed for testing the antibacterial activity. The medium was poured into sterile Petri dishes under aseptic conditions in a laminar air flow chamber. When the medium in the plates solidified, 0.5 mL of (week old) of culture from the test organism was inoculated and uniformly spread over the agar surface with a sterile L-shaped rod. Solutions were prepared by dissolving the synthesised 1-MAGs in DMSO and different concentrations were made. After inoculation, wells were scooped out with a 3 mm sterile cork borer and the lids were replaced onto the dishes. To each well different concentrations of test solutions were added. The controls were maintained. The treated and control samples were kept at 37&#x00B0; C for 24 h in an incubator. Inhibition zones were measured, the diameter was calculated in millimeters and the corresponding results were tabulated.</p>
</sec>
<sec id="s2d2">
<title>2.4.2. Determination of Minimum Inhibitory Concentration</title>
<p>The minimum inhibitory concentrations (MIC) of various synthetic compounds were tested against three representative Gram-positive organisms viz. <italic>Bacillus subtilis</italic> (MTCC 441), <italic>Staphylococcus aureus</italic> (MTCC 96), <italic>Staphylococcus epidermidis</italic> and Gram-negative organisms viz <italic>Escherichia coli</italic> (MTCC 443), <italic>Pseudomonas aeruginosa</italic> (MTCC 741), and <italic>Klebsiella pneumoniae</italic> (MTCC 618) according to the Microdilution method recommended by CLSI Standard Protocol (Clinical And Laboratory Standards Institute <xref ref-type="bibr" rid="cit0007">2008</xref>) in a liquid medium (Nutrient agar) distributed in 96-well plates. Serial dilutions of the tested compounds were performed (concentrations from 150 &#x03BC;g/mL to 0.97 &#x03BC;g/mL) in a culture medium with final volume of 200 &#x03BC;L and each well was seeded with a 50 &#x03BC;L microbial suspension of 0.5 MacFarland density. In each test a microbial culture control and a sterility control (negative) were prepared. The plates were incubated for 24 hours at 37 &#x00B0;C. The lowest concentration which inhibited the visible microbial growth was considered the MIC (&#x03BC;g/mL) value for the tested compound. The minimum inhibitory concentration (MIC) values are presented in <xref ref-type="table" rid="t0003">Table 3</xref>.</p>
</sec>
<sec id="s2d3">
<title>2.4.3. Cytotoxicity (MTT Assay)</title>
<p>The cell viability (MTT test) of the different test compounds was assessed following our earlier published literature (Kalpana <italic>et al</italic>., <xref ref-type="bibr" rid="cit0015">2018</xref>). To describe briefly: non-cancerous mammalian cells, CHO-K1 - ATCC<sup>&#x00AE;</sup> CCL-61&#x2122; (Chinese hamster ovary cells) collected from The Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, India and Cancer cell lines such as HeLa: Cervical cancer (ATCC<sup>&#x00AE;</sup> CCL2), B16-F10: Mouse skin melanoma (ATCC<sup>&#x00AE;</sup> CRL 6475&#x2122;), SKOV3: Human ovarian cancer (ATCC<sup>&#x00AE;</sup> HTB 77&#x2122;), MCF7: Human breast adenocarcinoma (ATCC<sup>&#x00AE;</sup> HTB-22&#x2122;) were obtained from ATCC (Bethesda, MD, USA). The cells were maintained in DMEM supplemented with 10% FBS, 2 mM L-glutamine, 100 U/mL penicillin, and 100 &#x03BC;g/mL streptomycin at 37 &#x00B0;C in a 5% CO2 incubator. The cultured cells were loaded into 96-well culture plate and allowed to attach properly. Each test compound of different concentrations ranging from 1 - 50 &#x03BC;M was treated in triplicate and incubated for 24 h. Doxorubicin for cancer cells and Mitomycin C for CHO cells were used as standard drugs for comparison. Then, 0.5 mg/mL of 3-(4,5-dimethyl-2-thiazolyl)- 2,5-diphenyl-2H-tetrazolium bromide (MTT) were added and incubated for 3 h. To each well, DMSO (100 &#x03BC;L) was added to dissolve the insoluble formazan crystals and the absorbance of the plates was measured using a Synergy H1Multi- Mode Plate Reader, USA.</p>
</sec>
</sec>
<sec id="sec2.5">
<title>2.5. Statistical analysis</title>
<p>Statistical analysis was carried out using Graph Pad Prism version 6.04 for Windows, Graph Pad Software, San Diego. The data were analyzed with unpaired Student&#x2019;s t-test, followed by &#x2018;&#x2018;One-way ANOVA&#x2019;&#x2019; by the Dunnett&#x2019;s multiple comparisons test.</p>
</sec>
</sec>
<sec id="sec3" sec-type="results|discussion">
<title>3. RESULTS AND DISCUSSION</title>
<sec id="sec3.1">
<title>3.1. Synthesis of 1-MAGs of unsaturated fatty acids</title>
<p>This study was intended to evaluate the antimicrobial and cytotoxic behavior of the 1-monoacylglycerols of selected unsaturated fatty acids. Among the selected fatty acids, GLA and ALA were obtained from urea complexation from borage and eri silkworm oils, respectively, whereas other fatty acids were commercially available. Eri silkworm oil and borage oil are reported to contain high amounts of ALA and GLA, respectively, and hence were taken as source oils for PUFAs. Urea complexation was carried out repeatedly to obtain maximum enrichment of the unsaturated fatty acids in the study. Ricinoleic acid was obtained from castor oil in pure form by selective extraction of hydroxy fatty acid using hexane and aqueous methanol solvent mixtures. <xref ref-type="table" rid="t0001">Table 1</xref> shows the composition of the initial and enriched fractions of unsaturated fatty acids.</p>
<table-wrap id="t0001">
<label>Table 1</label>
<caption>
<p>Fatty acid composition (wt%) of substrate oils and their enriched fractions</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left">Fatty acid</th>
<th align="center">SWO</th>
<th align="center">ALA-rich fraction from SWO</th>
<th align="center">Borage oil</th>
<th align="center">GLA-rich fraction from Borage oil</th>
<th align="center">Castor oil</th>
<th align="center">Ricinoleic acid-rich fraction from castor oil</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">14:0</td>
<td align="center">0.3 &#x00B1; 0.06</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">16:0</td>
<td align="center">24.9 &#x00B1; 0.94</td>
<td align="center">-</td>
<td align="center">10.0 &#x00B1;0.03</td>
<td align="center">-</td>
<td align="center">1.3 &#x00B1;0.33</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">16:1</td>
<td align="center">1.3 &#x00B1; 0.16</td>
<td align="center">-</td>
<td align="center">0.1 &#x00B1;0.01</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">18:0</td>
<td align="center">3.8 &#x00B1; 0.31</td>
<td align="center">-</td>
<td align="center">4.2 &#x00B1;0.03</td>
<td align="center">-</td>
<td align="center">1.2 &#x00B1;0.32</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">18:1</td>
<td align="center">13.2 &#x00B1; 0.27</td>
<td align="center">1.1 &#x00B1;0.01</td>
<td align="center">17.0 &#x00B1;0.07</td>
<td align="center">-</td>
<td align="center">4.3 &#x00B1;1.01</td>
<td align="center">0.3 &#x00B1;0.03</td>
</tr>
<tr>
<td align="left">18:2</td>
<td align="center">4.2 &#x00B1; 0.04</td>
<td align="center">4.7 &#x00B1;0.13</td>
<td align="center">37.3 &#x00B1;0.09</td>
<td align="center">4.1 &#x00B1;0.09</td>
<td align="center">5.0 &#x00B1;0.42</td>
<td align="center">0.4 &#x00B1;0.04</td>
</tr>
<tr>
<td align="left">18:1-O</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">88.2 &#x00B1;2.08</td>
<td align="center">99.3 &#x00B1;0.07</td>
</tr>
<tr>
<td align="left">18:3-A</td>
<td align="center">51.6 &#x00B1;0.57</td>
<td align="center">94.1 &#x00B1;0.13</td>
<td align="center">0.3 &#x00B1;0.04</td>
<td align="center">1.3 &#x00B1;0.06</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">18:3-G</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">22.4 &#x00B1;0.03</td>
<td align="center">94.6 &#x00B1;0.04</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">20:0</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">0.2 &#x00B1;0.01</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">20:1</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">4.1 &#x00B1;0.06</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">22:0</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">0.2 &#x00B1;0.01</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">22:1</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">2.6 &#x00B1;0.05</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">24:0</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">1.5 &#x00B1;0.01</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p><italic>SWO: silkworm oil; ALA: alpha linolenic acid: GLA: gamma linolenic acid</italic> &#x00B1;, Standard deviation of mean value of triplicates using Graph Pad Prism software</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>It can be observed that in both silkworm and borage oils, the PUFA fraction was selectively enriched with urea complexation, which is usually the method of choice for PUFA concentration (Hayes <italic>et al</italic>., <xref ref-type="bibr" rid="cit0011">1998</xref>). For the enrichment of ricinoleic acid, solvent fractionation was found to be the best and simplest method as it involved the partitioning of methyl ricinoleate in an aqueous methanol and hexane solvent mixture.</p>
<p>The synthesis of 1-monoacylglycerols of unsaturated fatty acids in the present study was carried out in two steps. Initially the fatty acids were esterified to solketal employing DCC as the coupling reagent and DMAP as the catalyst, which is a wellknown methodology for esterification (Yang <italic>et al</italic>., <xref ref-type="bibr" rid="cit0028">2012</xref>) at ambient temperatures to obtain the respective acetonides at 45-82% yields (<xref ref-type="fig" rid="f0001">Figure 1</xref>). Solketal is a readily available reagent commercially. Since our aim is to prepare 1-monoacyl glycerol, the esterification of fatty acids with solketal and deprotection of acetonide formed from fatty acid-solketal reaction yields the desired 1-monoacyl glycerol with no by-products. Therefore, we have employed solketal as one of the substrates.</p>
<fig id="f0001">
<label>Figure 1</label>
<caption>
<p>Synthetic route for 1-monoolein.</p>
</caption>
<graphic xlink:href="GYA201946_e325-1052182-g001.tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
<p>As fatty acids like ALA and GLA were enriched in their methyl ester form, an enzymatic transesterification route was found to be more suitable to avoid the hydrolysis of methyl esters and subsequent chemical esterification steps. This has not only reduced the number of steps but also provided an opportunity to include an enzymatic step which was a simple, mild and green methodology. The lipase employed for this transesterification was an immobilized lipase from <italic>Candida antarctica</italic> which is well known for its esterification and transesterification activities in organic media (Adlercreutz <xref ref-type="bibr" rid="cit0002">2013</xref>). Similarly, ricinoleic acid which is known to be unstable at ambient temperature was also enriched in its methyl ester form which was transesterified with solketal using lipase to obtain the corresponding acetonide (<xref ref-type="fig" rid="f0002">Figure 2</xref>) at a good yield. In the subsequent step, the acetonides were hydrolyzed in the presence of aqueous HCl at ambient temperature to obtain corresponding monoacylglycerols at 71-80% yields.</p>
<fig id="f0002">
<label>Figure 2</label>
<caption>
<p>Synthetic route for 1-monoricinolein.</p>
</caption>
<graphic xlink:href="GYA201946_e325-1052182-g002.tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
<p>The procedures using DCC/DMAP for esterification and the hydrolysis of acetonide with HCl were mild and the yields were also satisfactory. The products of esterification and deprotection were purified by column chromatography and characterized by IR, NMR and mass spectral data. The structures of the prepared 1-MAGs are shown in <xref ref-type="fig" rid="f0003">Figure 3</xref>.</p>
<fig id="f0003">
<label>Figure 3</label>
<caption>
<p>Structures of the 1-monoacylglycerols.</p>
</caption>
<graphic xlink:href="GYA201946_e325-1052182-g003.tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
</sec>
<sec id="sec3.2">
<title>3.2. Biological activity</title>
<p>The synthesized 1-MAGs were subjected to antimicrobial evaluation against both bacterial and fungal strains and also for cytotoxicity assay against five cell lines. It was found that the MAGs showed antibacterial action but were not found to exhibit antifungal activity. The antibacterial activity was tested against both Gram-positive and Gram-negative bacterial strains. The results of the antibacterial activity were measured as zone of inhibition (in mm) and are presented in <xref ref-type="table" rid="t0002">Table 2</xref>. The Gram-positive strains used in the study were <italic>Staphylococcus aureus, Staphylococcus epidermidis, Bacillus subtilis</italic> and the Gram-negative strains were <italic>Escherichia coli, Pseudomonas aeroginosa</italic> and <italic>Klebsiella pneumonia</italic>. Penicillin and streptomycin were used as standard reference antibiotic compounds and 1-monolaurin was used as lipidic reference.</p>
<table-wrap id="t0002">
<label>Table 2</label>
<caption>
<p>Bacterial zone of inhibition (mm) of test compounds</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left">Name of the Compound with code</th>
<th align="center">Staphylococcus aureus</th>
<th align="center">Staphylococcus epidermidis</th>
<th align="center">Bacillus subtilis</th>
<th align="center">Escherichia coli</th>
<th align="center">Pseudomonas aeruginosa</th>
<th align="center">Klebsiella pneumoniae</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">1-Monolaurin (lipid reference standard)</td>
<td align="center">15.8&#x00B1;0.7</td>
<td align="center">-</td>
<td align="center">18.8&#x00B1;0.7</td>
<td align="center">15&#x00B1;1</td>
<td align="center">18.33&#x00B1;0.5</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left"><bold>2a</bold> (UDA-MAG)</td>
<td align="center">11&#x00B1;0.5<sup><xref ref-type="table-fn" rid="tf2-1">a</xref></sup></td>
<td align="center">-</td>
<td align="center">8&#x00B1;1<sup><xref ref-type="table-fn" rid="tf2-1">a</xref></sup></td>
<td align="center">-</td>
<td align="center">19.66&#x00B1;0.5 <sup><xref ref-type="table-fn" rid="tf2-4">ns</xref></sup></td>
<td align="center">-</td>
</tr>
<tr>
<td align="left"><bold>2b</bold> (Oleic-MAG)</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left"><bold>2c</bold> (Linoleic-MAG)</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left"><bold>2d</bold> (GLA-MAG)</td>
<td align="center">18.6&#x00B1;0.5<sup><xref ref-type="table-fn" rid="tf2-1">a</xref></sup></td>
<td align="center">19.16&#x00B1;0.2<sup><xref ref-type="table-fn" rid="tf2-2">b</xref></sup></td>
<td align="center">22.5&#x00B1;0.5<sup><xref ref-type="table-fn" rid="tf2-1">a</xref></sup></td>
<td align="center">18.6&#x00B1;0.5<sup><xref ref-type="table-fn" rid="tf2-1">a</xref></sup></td>
<td align="center">20.33&#x00B1;1.1<sup><xref ref-type="table-fn" rid="tf2-3">c</xref></sup></td>
<td align="center">-</td>
</tr>
<tr>
<td align="left"><bold>2e</bold> (ALA-MAG)</td>
<td align="center">16.8&#x00B1;0.2 <sup><xref ref-type="table-fn" rid="tf2-4">ns</xref></sup></td>
<td align="center">-</td>
<td align="center">20.8&#x00B1;0.2<sup><xref ref-type="table-fn" rid="tf2-3">c</xref></sup></td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left"><bold>2f</bold> (Erucic-MAG)</td>
<td align="center">-</td>
<td align="center">20&#x00B1;0.5<sup><xref ref-type="table-fn" rid="tf2-2">b</xref></sup></td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left"><bold>2g</bold> (Ricinoleic-MAG)</td>
<td align="center">11.6&#x00B1;0.5<sup><xref ref-type="table-fn" rid="tf2-1">a</xref></sup></td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
<tr>
<td align="left">Penicillin (standard)</td>
<td align="center">28&#x00B1;0.2<sup><xref ref-type="table-fn" rid="tf2-1">a</xref></sup></td>
<td align="center">25.83&#x00B1;0.28</td>
<td align="center">27.6&#x00B1;0.5<sup><xref ref-type="table-fn" rid="tf2-1">a</xref></sup></td>
<td align="center">24.16&#x00B1;0.7<sup><xref ref-type="table-fn" rid="tf2-1">a</xref></sup></td>
<td align="center">23.16&#x00B1;0.28<sup><xref ref-type="table-fn" rid="tf2-1">a</xref></sup></td>
<td align="center">25.33&#x00B1;0.5</td>
</tr>
<tr>
<td align="left">Streptomycin</td>
<td align="center">22.8&#x00B1;0.2<sup><xref ref-type="table-fn" rid="tf2-1">a</xref></sup></td>
<td align="center">25.16&#x00B1;0.2</td>
<td align="center">24&#x00B1;1<sup><xref ref-type="table-fn" rid="tf2-1">a</xref></sup></td>
<td align="center">23.3&#x00B1;0.5<sup><xref ref-type="table-fn" rid="tf2-1">a</xref></sup></td>
<td align="center">27.33&#x00B1;0.5<sup><xref ref-type="table-fn" rid="tf2-1">a</xref></sup></td>
<td align="center">26.16&#x00B1;0.2</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x00B1;, Mean value with standard error of mean of triplicates; &#x2018;&#x2018;One-way ANOVA&#x2019;&#x2019; used to measure the mean differences among the compounds by the Dunnett&#x2019;s multiple comparisons test.</p></fn>
<fn id="tf2-1">
<label>a</label><p>Significantly different from (lipid reference standard, 1-Monolaurin) at P &#x003C; 0.001;</p></fn>
<fn id="tf2-2">
<label>b</label><p>Significantly different from Penicillin at P &#x003C; 0.001;</p></fn>
<fn id="tf2-3">
<label>c</label><p>Significantly different from (lipid reference standard, 1-Monolaurin) at P &#x003C; 0.05;</p></fn>
<fn id="tf2-4">
<label>ns</label><p>notsignificant</p></fn>
</table-wrap-foot>
</table-wrap>
<p>It was observed that most of the prepared 1-MAGs were more effective against Gram-positive bacteria compared to Gram-negative bacteria. Among the lipids, GLA-MAG showed a broad spectrum antibacterial activity against all the tested strains except against <italic>Klebsiella pneumonia</italic>. When analyzing the susceptibility of the lipids against various bacterial strains according to zone of inhibition, GLA-MAG against <italic>Staphylococcus aureu;</italic> ALA-MAG against <italic>Bacillus subtilis</italic> and Erucic-MAG against <italic>Staphylococcus epidermidis</italic> exhibited higher antimicrobial action. To further investigate the efficacy of the prepared MAGs, minimum inhibitory concentration (MIC in &#x03BC;g/mL) was also determined (<xref ref-type="table" rid="t0003">Table 3</xref>).</p>
<table-wrap id="t0003">
<label>Table 3</label>
<caption>
<p>Minimum Inhibitory Concentration (&#x03BC;g/mL) of test compounds</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left">Compound</th>
<th align="center">Staphylococcus aureus</th>
<th align="center">Staphylococcus epidermidis</th>
<th align="center">Bacillus subtilis</th>
<th align="center">Escherichia coli</th>
<th align="center">Pseudomonas aeruginosa</th>
<th align="center">Klebsiella pneumoniae</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><bold>2a</bold> (UDA-MAG)</td>
<td align="center">150</td>
<td align="center">&#x003E;150</td>
<td align="center">150</td>
<td align="center">&#x003E;150</td>
<td align="center">9.37</td>
<td align="center">&#x003E;150</td>
</tr>
<tr>
<td align="left"><bold>2b</bold> (Oleic-MAG)</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
</tr>
<tr>
<td align="left"><bold>2c</bold> (Linoleic-MAG)</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
</tr>
<tr>
<td align="left"><bold>2d</bold> (GLA-MAG)</td>
<td align="center">18.75</td>
<td align="center">37.5</td>
<td align="center">4.74</td>
<td align="center">37.5</td>
<td align="center">9.37</td>
<td align="center">&#x003E;150</td>
</tr>
<tr>
<td align="left"><bold>2e</bold> (ALA-MAG)</td>
<td align="center">37.5</td>
<td align="center">&#x003E;150</td>
<td align="center">9.37</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
</tr>
<tr>
<td align="left"><bold>2f</bold> (Erucic-MAG)</td>
<td align="center">&#x003E;150</td>
<td align="center">9.37</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
</tr>
<tr>
<td align="left"><bold>2g</bold> (Ricinoleic-MAG)</td>
<td align="center">150</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
<td align="center">&#x003E;150</td>
</tr>
<tr>
<td align="left">1-Monolaurin</td>
<td align="center">37.5</td>
<td align="center">&#x003E;150</td>
<td align="center">18.75</td>
<td align="center">37.5</td>
<td align="center">18.75</td>
<td align="center">&#x003E;150</td>
</tr>
<tr>
<td align="left"><bold>Standard Drug</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left">Penicillin</td>
<td align="center">1.562</td>
<td align="center">3.125</td>
<td align="center">1.562</td>
<td align="center">12.5</td>
<td align="center">12.5</td>
<td align="center">6.25</td>
</tr>
<tr>
<td align="left">Streptomycin</td>
<td align="center">6.25</td>
<td align="center">3.125</td>
<td align="center">6.25</td>
<td align="center">6.25</td>
<td align="center">1.562</td>
<td align="center">3.125</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Media values are represented in &#x03BC;g/mL of serial dilution of two replicates. For all the test compounds, the highest concentration was used at 150 &#x03BC;g/mL and lowest concentration used at 2.34 &#x03BC;g/mL; whereas, for standards (Penicillin and Strepotomycin) the highest concentration used at 100 &#x03BC;g/mL and lowest concentration at 0.78 &#x03BC;g/mL. Values with &#x003E; 150 are considered to show no antibacterial activity.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>After the MAG of GLA, the next active MAG was observed to be of ALA, which showed inhibition against <italic>Staphylococcus aureus</italic> and <italic>Bacillus subtilis</italic> with MIC values of 37.5 and 9.37 &#x03BC;g/mL, respectively. It was noted that the MAG of ricinoleic acid showed moderate activity against <italic>Staphylococcus aureus</italic>. In this study, the MAG of undecenoic acid was found to be active against two Gram-positive and one Gram-negative bacterial strains. The MIC value of UDA-MAG against <italic>Staphylococcus aureus</italic> in the present study was 150 &#x03BC;g/mL, which was comparable to the value determined in a previously reported study (Dolezalova <italic>et al</italic>., <xref ref-type="bibr" rid="cit0009">2010</xref>). It was reported that undecenoic acid was better known for its antifungal activity rather than antibacterial activity (Marijke and Stevens 2009). However, in the present study, it was found that MAGs with longer fatty acid chains were more effective compared to MAGs of undecenoic acid in terms of zone of inhibition. Earlier studies also reported that an increase in unsaturation of long-chain fatty acids has a positive effect on the antimicrobial action of fatty acids compared to saturated and shorter-chain fatty acids (Thormar and Hilmarsson <xref ref-type="bibr" rid="cit0027">2007</xref>). It was interesting to observe that the MAG of erucic acid was active only against <italic>Staphylococcus epidermidis</italic> along with the MAG of GLA and no other MAG was effective against this bacteria, including monolaurin. The MIC value of the MAG of erucic acid was 9.37 &#x03BC;g/mL, whereas GLA-MAG showed an MIC of 37.5 &#x03BC;g/mL, which indicated that a very long-chain monounsaturated fatty acid was selectively active on this strain. In this study, GLA-MAG was observed to be the most active compound among all the MAGs tested. As monolaurin is the most widely known antimicrobial compound, we tried to compare the antimicrobial properties of the prepared MAGs with monolaurin. It was found that the MAG of GLA was more effective than 1-monolaurin against all the strains where monolaurin showed activity. Both zones of inhibitions and the MIC values of GLA-MAG were better than monolaurin. It was found that GLA-MAG was the most potent MAG against <italic>Bacillus subtilis</italic> with a MIC value of 4.74 &#x03BC;g/mL, which was better than standard streptomycin which showed an MIC value of 6.25 &#x03BC;g/mL. Many studies conducted earlier also reported similar observations where several antimicrobial lipids were shown to exhibit greater activity against Gram-positive bacteria species over Gram-negative species (Yoon <italic>et al</italic>., <xref ref-type="bibr" rid="cit0029">2018</xref>). Against Gram-negative bacteria viz <italic>Pseudomonas aeruginosa</italic>, both GLA-MAG and UDA-MAG showed a MIC value of 9.37 &#x03BC;g/mL, which is better than one of the standard antibiotic penicillins which showed a MIC of 12.5 &#x03BC;g/mL. Against <italic>E. coli</italic>, only GLA-MAG exhibited moderate activity with a MIC of 37.5 &#x03BC;g/mL, which was comparable to monolaurin but lower than both standard antibiotics. It was also found that monolaurin was not active against <italic>Staphylococcus epidermidis</italic> whereas GLA-MAG and erucic-MAG showed better activity against this strain compared to monolaurin with MIC values of 37.5 and 9.37 &#x03BC;g/mL, respectively.</p>
<p>The cytotoxicity evaluation for the prepared MAGs was carried out by the widely employed MTT assay and the results are presented in <xref ref-type="table" rid="t0004">Table 4</xref>. From the cytotoxicity assay, it can be observed that all of the MAGs were found to show moderate activity compared to the standard drug. However, the MAGs showed better activity against MCF-7 cell lines compared to the other cell lines. Each MAG showed different activity against different cell lines. According to their IC<sub>50</sub> values, it was found that erucic-MAG showed the highest activity against HeLa, ALA-MAG against B16-F10, ricinoleic-MAG against SKOV3, GLA-MAG against MCF-7 and the oleic MAG against CHO-K1.</p>
<table-wrap id="t0004">
<label>Table 4</label>
<caption>
<p>in vitro cytotoxicity test of compounds (&#x03BC;M) against cancerous and non-cancerous cell lines</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left">S.No</th>
<th align="center">Test compound</th>
<th colspan="5" align="center">IC50 values (&#x03BC;M)<hr/></th>
</tr>
<tr>
<th align="left"/>
<th align="center"/>
<th align="center">HeLa</th>
<th align="center">B16-F10</th>
<th align="center">SKOV3</th>
<th align="center">MCF-7</th>
<th align="center">CHO-K1</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">1</td>
<td align="left"><bold>2a</bold> (UDA-MAG)</td>
<td align="center">35.62 &#x00B1; 0.20</td>
<td align="center">42.12 &#x00B1; 0.08</td>
<td align="center">31.10 &#x00B1; 0.18</td>
<td align="center">15.32 &#x00B1; 0.05</td>
<td align="center">73.29 &#x00B1; 2.2</td>
</tr>
<tr>
<td align="left">2</td>
<td align="left"><bold>2b</bold> (Oleic-MAG)</td>
<td align="center">28.35 &#x00B1; 0.28</td>
<td align="center">97.36 &#x00B1; 0.10</td>
<td align="center">21.89 &#x00B1; 0.08</td>
<td align="center">23.03 &#x00B1;0.01</td>
<td align="center">30.03 &#x00B1; 1.7</td>
</tr>
<tr>
<td align="left">3</td>
<td align="left"><bold>2c</bold> (Linoleic-MAG)</td>
<td align="center">32.13 &#x00B1; 0.15</td>
<td align="center">45.25 &#x00B1; 0.96</td>
<td align="center">27.34 &#x00B1; 0.85</td>
<td align="center">16.60 &#x00B1; 0.11</td>
<td align="center">43.32 &#x00B1;0.28</td>
</tr>
<tr>
<td align="left">4</td>
<td align="left"><bold>2e</bold> (ALA-MAG)</td>
<td align="center">27.54 &#x00B1; 0.38</td>
<td align="center">44.04 &#x00B1; 0.15</td>
<td align="center">53.53 &#x00B1; 2.2</td>
<td align="center">16.42 &#x00B1; 0.21</td>
<td align="center">39.93 &#x00B1; 0.23</td>
</tr>
<tr>
<td align="left">5</td>
<td align="left"><bold>2d</bold> (GLA-MAG)</td>
<td align="center">25.55 &#x00B1; 0.58</td>
<td align="center">62.93 &#x00B1; 0.83</td>
<td align="center">26.75 &#x00B1; 0.10</td>
<td align="center">13.32 &#x00B1; 0.15</td>
<td align="center">28.97 &#x00B1; 0.27</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left"><bold>2f</bold> (Erucic-MAG)</td>
<td align="center">23.98 &#x00B1; 0.79</td>
<td align="center">52.96 &#x00B1; 0.72</td>
<td align="center">44.65 &#x00B1; 0.60</td>
<td align="center">13.91 &#x00B1; 0.01</td>
<td align="center">51.61 &#x00B1; 0.12</td>
</tr>
<tr>
<td align="left">7</td>
<td align="left"><bold>2g</bold> (Ricinoleic-MAG)</td>
<td align="center">24.61 &#x00B1; 0.37</td>
<td align="center">99.20 &#x00B1; 2.0</td>
<td align="center">20.55 &#x00B1; 0.77</td>
<td align="center">15.60 &#x00B1; 0.07</td>
<td align="center">33.02 &#x00B1; 0.44</td>
</tr>
<tr>
<td align="left">8</td>
<td align="left">1-Monolaurin</td>
<td align="center">25.60 &#x00B1; 0.15</td>
<td align="center">69.79 &#x00B1; 1.3</td>
<td align="center">31.35 &#x00B1; 0.03</td>
<td align="center">15.64 &#x00B1; 0.06</td>
<td align="center">50.25 &#x00B1; 1.3</td>
</tr>
<tr>
<td colspan="2">
<bold>Standard Drug</bold>- Doxorubicin</td>
<td align="center">0.8 &#x00B1; 0.71</td>
<td align="center">0.7 &#x00B1; 0.56</td>
<td align="center">0.8 &#x00B1; 0.63</td>
<td align="center">2.0 &#x00B1; 0.81</td>
<td align="center">NA</td>
</tr>
<tr>
<td colspan="2">Mitomycin C</td>
<td align="center">NA</td>
<td align="center">NA</td>
<td align="center">NA</td>
<td align="center">NA</td>
<td align="center">13.1 &#x00B1; 0.68</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Cancer cell lines: (HeLa, Homo sapiens cervix adenocarcinoma; B16-F10, Mouse skin melanoma (ATCC<sup>&#x00AE;</sup> CRL 6475<sup>&#x2122;</sup>); SKOV3, Human Ovarian cancer (ATCC<sup>&#x00AE;</sup> HTB 77<sup>&#x2122;</sup>); MCF7, Human Breast Adenocarcinoma (ATCC<sup>&#x00AE;</sup> HTB-22<sup>&#x2122;</sup>); Non-cancerous cell lines (CHO-K1, Chinese Hamster Ovary cells (ATCC<sup>&#x00AE;</sup> CCL-61&#x2122;); &#x00B1;, Standard deviation of mean value of triplicates using Graph Pad Prism software; NA, no activity.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The present study was helpful in assessing the antimicrobial and cytotoxicity potential of the 1-MAGs of some of the unsaturated fatty acids and further studies on a range of 1-MAGs of different fatty acids could be of interest in view of developing biocompatible biologically active agents.</p>
</sec>
</sec>
<sec id="sec4" sec-type="conclusions">
<title>4. CONCLUSIONS</title>
<p>The synthesis of structured 1-monoacylglycerols comprising unsaturated fatty acids and their antimicrobial and cytotoxicity efficacies were studied. Among the prepared lipid derivatives, the monoacylglycerol of gamma linolenic acid was found to be the most effective against both Gram-positive and Gram-negative bacterial strains. All the MAGs prepared exhibited moderate cytotoxicity activity against a panel of cell lines. However, further studies are needed to exploit the full potential of these monoacylglycerol derivatives with different types of fatty acids to test in food-based systems for additional applications.</p>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGMENTS</title>
<p>Ms Juliya Johny and Dr. Shiva Shanker Kaki gratefully acknowledge the Science and Engineering Research Board, Department of Science &#x0026; Technology, New Delhi, for financial assistance under the Early Career Research Award [project file number ECR12017/000639] and the Director, CSIR-IICT, for providing the facilities.</p>
<p>IICT Communication number: IICT/Pubs./2018/291.</p>
</ack>
<ref-list>
<title>REFERENCES</title>
<ref id="cit0001">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aarti</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Louk</surname>
<given-names>ARMP</given-names>
</name>
<name>
<surname>Potts</surname>
<given-names>RO</given-names>
</name>
<name>
<surname>Guy</surname>
<given-names>RH</given-names>
</name>
</person-group>
<article-title>Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans</article-title>
<source>J. Cont. Release</source>
<year>1995</year>
<volume>37</volume>
<fpage>299</fpage>
<lpage>306</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/0168-3659(95">https://doi.org/10.1016/0168-3659(95)00088-7</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0002">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adlercreutz</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Immobilisation and application of lipases in organic media</article-title>
<source>Chem. Soc. Rev.</source>
<year>2013</year>
<volume>42</volume>
<fpage>6406</fpage>
<lpage>6436</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1039/C3CS35446F">https://doi.org/10.1039/C3CS35446F</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0003">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altieri</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bevilacqua</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cardillo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sinigaglia</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Effectiveness of fatty acids and their monoglycerides against gram-negative pathogens</article-title>
<source>Int. J. Food Sci. Technol.</source>
<year>2009</year>
<volume>44</volume>
<fpage>359</fpage>
<lpage>366</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1365-2621.2008.01744.x">https://doi.org/10.1111/j.1365-2621.2008.01744.x</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0004">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berdeaux</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Christie</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Gunstone</surname>
<given-names>FD</given-names>
</name>
<name>
<surname>Sebedio</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Large-scale synthesis of methyl cis-9,trans-11-octadecadienoate from methyl ricinoleate</article-title>
<source>J. Am. Oil Chem. Soc.</source>
<year>1997</year>
<volume>74</volume>
<fpage>1011</fpage>
<lpage>1015</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11746-997-0018-z">https://doi.org/10.1007/s11746-997-0018-z</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0005">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bornscheuer</surname>
<given-names>UT</given-names>
</name>
</person-group>
<article-title>Lipase-Catalyzed Syntheses of Monoglycerols</article-title>
<source>Enzyme Microb. Technol.</source>
<year>1995</year>
<volume>17</volume>
<fpage>578</fpage>
<lpage>586</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/0141-0229(94)00096-A">https://doi.org/10.1016/0141-0229(94)00096-A</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0006">
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Christie</surname>
<given-names>WW</given-names>
</name>
</person-group>
<year>1982</year>
<source>The preparation of derivatives of lipids. Lipid Analysis</source>
<edition>2</edition>
<publisher-name>Pergamon Press Ltd.</publisher-name>
<publisher-loc>Oxford, United Kingdom</publisher-loc>
<fpage>51</fpage>
<lpage>61</lpage>
</mixed-citation>
</ref>
<ref id="cit0007">
<mixed-citation publication-type="standard">
<person-group person-group-type="author">
<collab>Clinical and Laboratory Standards Institute</collab>
</person-group>
<year>2008</year>
<source>Performance Standards for Antimicrobial Susceptibility Tests; Eighteen informational supplement M100-S18</source>
</mixed-citation>
</ref>
<ref id="cit0008">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desbois</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Lawlor</surname>
<given-names>KC</given-names>
</name>
</person-group>
<article-title>Antibacterial activity of long-chain polyunsaturated fatty acids against Propionibacterium acnes and <italic>Staphylococcus aureus</italic></article-title>
<source>Mar. Drugs</source>
<year>2013</year>
<volume>11</volume>
<fpage>4544</fpage>
<lpage>4557</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/md11114544">https://doi.org/10.3390/md11114544</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0009">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dolezalova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Janis</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Svobodova</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kasparkova</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Humpol&#x0131;cek</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Krejci</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Antimicrobial properties of 1-monoacylglycerols prepared from undecanoic (C11:0) and undecenoic (C11:1) acid</article-title>
<source>Eur. J. Lipid Sci. Technol.</source>
<year>2010</year>
<volume>112</volume>
<fpage>1106</fpage>
<lpage>1114</lpage>
<comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ejlt.200900295">https://doi.org/10.1002/ejlt.200900295</ext-link></comment>
</nlm-citation>
</ref>
<ref id="cit0010">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flider</surname>
<given-names>FJ</given-names>
</name>
</person-group>
<article-title>GLA: Uses and new sources</article-title>
<source>INFORM</source>
<year>2005</year>
<volume>16</volume>
<fpage>279</fpage>
<lpage>282</lpage>
</nlm-citation>
</ref>
<ref id="cit0011">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayes</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Bengtsson</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Van Alstine</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Setterwall</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Urea complexation for the rapid, ecologically responsible fractionation of fatty acids from seed oil</article-title>
<source>J. Amer. Oil Chem. Soc.</source>
<year>1998</year>
<volume>75</volume>
<fpage>1403</fpage>
<lpage>1409</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11746-998-0190-9">https://doi.org/10.1007/s11746-998-0190-9</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0012">
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Kabara</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>DL</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Davidson</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Sofos</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Branen</surname>
<given-names>AL</given-names>
</name>
</person-group>
<year>2005</year>
<chapter-title>Medium-chain fatty acids and esters</chapter-title>
<source>Antimicrobials in Food</source>
<publisher-name>CRC Press</publisher-name>
<publisher-loc>Boca Raton, USA</publisher-loc>
<fpage>327</fpage>
<lpage>360</lpage>
</mixed-citation>
</ref>
<ref id="cit0013">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kabara</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Swieczkowski</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Conley</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Truant</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Fatty acids and derivatives as antimicrobial agents</article-title>
<source>Antimicrob. Agents Chemother</source>
<year>1972</year>
<volume>2</volume>
<fpage>23</fpage>
<lpage>28</lpage>
</nlm-citation>
</ref>
<ref id="cit0014">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaki</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Ravinder</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ashwini</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>BVSK</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>RBN</given-names>
</name>
</person-group>
<article-title>Enzymatic modification of phosphatidylcholine with n-3 PUFA from silkworm oil fatty acids</article-title>
<source>Grasas Aceites</source>
<year>2014</year>
<volume>65</volume>
<fpage>e021</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3989/gya.097213">https://doi.org/10.3989/gya.097213</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0015">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalpana</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gousia</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Shruti</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Rohit</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Sunil</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Potential of the bioinspired CaCo3 microspheres loaded with tetracycline in inducing differential cytotoxic effects toward noncancerous and cancer cells: a cytogenetic toxicity assessment using CHO cells in vitro</article-title>
<source>Chem. Res. Toxicol.</source>
<year>2018</year>
<volume>31</volume>
<fpage>629</fpage>
<lpage>636</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/acs.chemrestox.8b00131">https://doi.org/10.1021/acs.chemrestox.8b00131</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0016">
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Linday</surname>
<given-names>ME</given-names>
</name>
</person-group>
<year>1962</year>
<source>Practical Introduction to Microbiology</source>
<publisher-name>E and F.N. Spon Ltd.</publisher-name>
<publisher-loc>United Kingdom</publisher-loc>
<size units="page">177</size>
</mixed-citation>
</ref>
<ref id="cit0017">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Littich</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Antimicrobial lipids: attenuating the use of medically important antimicrobial drugs in food-producing animals: What role Can cGMP lipids play?</article-title>
<source>Drug Dev. Del.</source>
<year>2017</year>
<volume>17</volume>
<fpage>56</fpage>
<lpage>61</lpage>
</nlm-citation>
</ref>
<ref id="cit0018">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>Al</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Improved bioavailability of encapsulated bioactive nutrients delivered through monoglyceride-structured o/w emulsions</article-title>
<source>J. Agric. Food Chem.</source>
<year>2017</year>
<volume>65</volume>
<fpage>3048</fpage>
<lpage>3055</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/acs.jafc.6b05644">https://doi.org/10.1021/acs.jafc.6b05644</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0019">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maryam</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Stephanie</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Lyn</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>FB</given-names>
</name>
</person-group>
<article-title>Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies</article-title>
<source>Circulation</source>
<year>2014</year>
<volume>130</volume>
<fpage>1568</fpage>
<lpage>1578</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCULATIONAHA.114.010236">https://doi.org/10.1161/CIRCULATIONAHA.114.010236</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0020">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguemeni</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gouix</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bourourou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Heurteaux</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Blondeau</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Alpha-linolenic acid: A promising nutraceutical for the prevention of stroke</article-title>
<source>Pharm. Nutrition</source>
<year>2013</year>
<volume>1</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.phanu.2012.12.002">https://doi.org/10.1016/j.phanu.2012.12.002</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0021">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osborn</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Akoh</surname>
<given-names>CC</given-names>
</name>
</person-group>
<article-title>Structured lipids &#x2013; Novel fats with medical, nutraceutical and food applications</article-title>
<source>Compr. Rev. Food Sci. Food Saf.</source>
<year>2002</year>
<volume>3</volume>
<fpage>110</fpage>
<lpage>120</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1541-4337.2002.tb00010.x">https://doi.org/10.1111/j.1541-4337.2002.tb00010.x</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0022">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pabi&#x015B;</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kula</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Synthesis and bioactivity of (r)-ricinoleic acid derivatives: A review</article-title>
<source>Curr. Med. Chem.</source>
<year>2016</year>
<volume>23</volume>
<fpage>4037</fpage>
<lpage>4056</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2174/0929867323666160627104453">https://doi.org/10.2174/0929867323666160627104453</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0023">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pawongrat</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kittikun</surname>
<given-names>AH</given-names>
</name>
</person-group>
<article-title>Physico-enzymatic production of monoacylglycerols enriched with very-long-chain polyunsaturated fatty acids</article-title>
<source>J. Sci. Food Agric.</source>
<year>2008</year>
<volume>88</volume>
<fpage>256</fpage>
<lpage>262</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jsfa.3081">https://doi.org/10.1002/jsfa.3081</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0024">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pierard</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Arrese</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Pierard-Franchimont</surname>
<given-names>C</given-names>
</name>
<name>
<surname>De Doncker</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Prolonged effects of anti-dandruff shampoos &#x2013; time to recurrence of Malassezia ovalis colonisation of skin</article-title>
<source>Int. J. Cosmet. Sci.</source>
<year>1997</year>
<volume>19</volume>
<fpage>111</fpage>
<lpage>117</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1467-2494.1997.tb00174.x">https://doi.org/10.1111/j.1467-2494.1997.tb00174.x</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0025">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janis</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Krejc&#x00ED;</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kl&#x00E1;sek</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Preparation of 1-monoacylglycerols from glycidol and fatty acids catalyzed by the chromium(III)- fatty acid system</article-title>
<source>Eur. J. Lipid Sci. Technol.</source>
<year>2000</year>
<volume>102</volume>
<fpage>351</fpage>
<lpage>354</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/(SICI)1438-9312(200005)102:5&#x003C;351::AID-EJLT351&#x003E;3.0.CO;2-J">https://doi.org/10.1002/(SICI)1438-9312(200005)102:5&#x003C;351::AID-EJLT351&#x003E;3.0.CO;2-J</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0026">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonntag</surname>
<given-names>NOV</given-names>
</name>
</person-group>
<article-title>Glycerolysis of fats and methylesters-Status, review and critique</article-title>
<source>J. Am. Oil Chem. Soc.</source>
<year>1982</year>
<volume>59</volume>
<fpage>795A</fpage>
<lpage>802A</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/BF02634442">https://doi.org/10.1007/BF02634442</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0027">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thormar</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hilmarsson</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents</article-title>
<source>Chem. Phys. Lipids</source>
<year>2007</year>
<volume>150</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.chemphyslip.2007.06.220">https://doi.org/10.1016/j.chemphyslip.2007.06.220</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0028">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cwynar</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Madanmohan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lyons</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Caffrey</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Preparation of 1-monoacylglycerols via the Suzuki-Miyaura reaction: 2, 3-dihydroxypropyl (Z)-tetradec-7-enoate</article-title>
<source>Org. Synth.</source>
<year>2012</year>
<volume>89</volume>
<fpage>183</fpage>
<lpage>201</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/0471264229.os089.19">https://doi.org/10.1002/0471264229.os089.19</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0029">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Jackman</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Valle-Gonz&#x00E1;lez</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>NJ</given-names>
</name>
</person-group>
<article-title>Antibacterial free fatty acids and monoglycerides: Biological activities, experimental testing, and therapeutic applications</article-title>
<source>Int. J. Mol. Sci.</source>
<year>2018</year>
<volume>19</volume>
<fpage>1114</fpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/ijms19041114">https://doi.org/10.3390/ijms19041114</ext-link>
</comment>
</nlm-citation>
</ref>
<ref id="cit0030">
<nlm-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Jung-Sung</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tae-Gyu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hee-Young</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Young-Ho</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Won-Gon</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids</article-title>
<source>FEBS Lett.</source>
<year>2005</year>
<volume>579</volume>
<fpage>5157</fpage>
<lpage>5162</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.febslet.2005.08.028">https://doi.org/10.1016/j.febslet.2005.08.028</ext-link>
</comment>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>